Drugs / RIV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06237049 | Jan → Sep 2024 | COVID-19, influenza | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06237049 ↗ |
| Modality | Vaccine | “recombinant influenza vaccine (RIV)” NCT06237049 ↗ |